# OSGIN1

## Overview
OSGIN1, or oxidative stress induced growth inhibitor 1, is a gene that encodes a protein involved in cellular responses to oxidative stress. The protein, also referred to as OSGIN1, is categorized as an oxidoreductase due to its conserved oxidoreductase domains, which play a significant role in the oxidative stress response (Brennan2015The). OSGIN1 is a transcriptional target of the Nrf2 pathway and is implicated in regulating inflammation, cell cycle, and apoptosis, particularly in cancer cells (Brennan2015The). The protein exists in multiple isoforms, with the 61 kDa variant being the canonical sequence associated with cytoprotective and anti-inflammatory effects (Brennan2015The). OSGIN1's interactions with proteins such as p53 and PADI4 highlight its involvement in complex regulatory networks that modulate cell proliferation and cytoprotection (Brennan2017The). Clinically, alterations in OSGIN1 expression are linked to various cancers, including hepatocellular carcinoma and breast cancer, where it functions as a tumor suppressor (Tsai2017Docosahexaenoic; Liu2014AlleleSpecific).

## Structure
The OSGIN1 protein, also known as oxidative stress-induced growth inhibitor 1, is characterized by multiple isoforms resulting from alternative splicing. The primary structure of OSGIN1 includes several isoforms, notably the 52 kDa, 61 kDa, and 38 kDa variants. The 61 kDa isoform is considered the canonical sequence and is associated with cytoprotective and anti-inflammatory effects, particularly in astrocytes (Brennan2015The; Brennan2017The). The 52 kDa isoform is known for its potency in inducing apoptosis and inhibiting cell proliferation, especially in cancer cell lines (Brennan2015The).

OSGIN1 is a transcriptional target of the Nrf2 pathway and is involved in cellular responses to oxidative stress. It contains conserved oxidoreductase domains, suggesting a role in oxidative stress response (Brennan2015The). The protein's regulation involves translational suppression via small upstream open reading frames (uORFs) in the 5' untranslated region (UTR) (Brennan2015The).

The protein's function is influenced by its interaction with the tumor suppressor protein p53, with which it can co-localize in mitochondria, affecting mitochondrial morphology and inducing apoptosis through cytochrome C release (Brennan2015The). The translocation of OSGIN1 from the nucleus to the mitochondria is crucial for its pro-apoptotic effect (Liu2014AlleleSpecific).

## Function
OSGIN1, or oxidative stress induced growth inhibitor 1, is a gene that encodes a protein involved in cellular responses to oxidative stress. It plays a crucial role in regulating inflammation and the cell cycle in human cells. OSGIN1 acts as a major hub gene in response to oxidized lipid products, such as Ox-PAPC, which accumulate in atherosclerotic lesions and other chronic inflammatory sites. The loss of OSGIN1 leads to increased expression of inflammatory markers like interleukin-8 (IL-8), ATF-4, and KLF4, highlighting its protective role against inflammation (Brennan2015The).

OSGIN1 is a transcriptional target of the Nrf2 pathway, which is involved in oxidative stress responses. Its expression is induced by oxidative signals, and it contributes to the cytoprotective properties of monomethyl fumarate (MMF) by enhancing cellular resistance to oxidative damage (Brennan2015The). In human astrocytes, OSGIN1 is regulated by Nrf2 and contributes to cytoprotection against oxidative stress, with its 61 kDa isoform being predominantly regulated in an Nrf2-dependent manner (Brennan2015The).

OSGIN1 is also involved in cell growth arrest and apoptosis, particularly in cancer cells, where its expression is linked to these processes (Brennan2015The). The protein is active in both the cytoplasm and nucleus, influencing processes like cell cycle regulation and stress response, thereby contributing to cellular homeostasis and organismal health (Brennan2015The).

## Clinical Significance
Mutations and alterations in the expression of the OSGIN1 gene have significant clinical implications, particularly in cancer. In hepatocellular carcinoma (HCC), OSGIN1 acts as a tumor suppressor. Its downregulation is observed in approximately 24.7% of HCC specimens and is associated with poorer overall survival and disease-free survival times (Liu2014AlleleSpecific). The presence of the 1494A variant of OSGIN1, which results in an amino acid substitution, is linked to reduced apoptosis and poorer patient outcomes, as it is less effective in inducing apoptosis compared to the common form (Liu2014AlleleSpecific). This variant is often retained in tumor tissues due to loss of heterozygosity, suggesting its role in HCC progression (Liu2014AlleleSpecific).

In breast cancer, OSGIN1 expression is generally low compared to normal tissue, and its upregulation by docosahexaenoic acid (DHA) through the PI3K/Akt/Nrf2 signaling pathway is associated with increased apoptosis, highlighting its potential tumor-suppressing properties (Tsai2017Docosahexaenoic). Additionally, OSGIN1 is downregulated in kidney tumors, correlating with advanced tumor stages and decreased patient survival (Brennan2015The). These findings underscore the gene's role in cancer progression and its potential as a therapeutic target.

## Interactions
OSGIN1, or oxidative stress induced growth inhibitor 1, is involved in several interactions with other proteins, particularly in the context of oxidative stress and cytoprotection. OSGIN1 is a transcriptional target of the NRF2 pathway and plays a role in mediating cytoprotective effects in human astrocytes through its interaction with the P53 protein. It is suggested that OSGIN1 regulates the translocation of P53 to the nucleus, which is crucial for P53-mediated transcriptional control and cytoprotection against oxidative stress (Brennan2017The). 

OSGIN1 also interacts with PADI4, a protein involved in cell-cycle control, where P53 regulates PADI4 expression independently of NRF2. This interaction suggests a complex regulatory network involving OSGIN1, P53, and PADI4 in modulating cell proliferation and cytoprotection (Brennan2017The). 

In breast cancer cells, OSGIN1 is implicated in mitochondrial localization and the regulation of apoptosis. It interacts with P53 and Bax, contributing to cytochrome c release and apoptosis, highlighting its role in the regulation of mitochondrial p53 localization and p53-dependent apoptotic pathways (Tsai2017Docosahexaenoic). 

These interactions underscore OSGIN1's involvement in cellular stress responses and its potential as a therapeutic target in diseases characterized by oxidative stress.


## References


[1. (Brennan2015The) Melanie Brennan, Maria Matos, Chao Sun, Suzanne Szak, and Robert Scannevin. The nrf2 transcriptional target, osgin1, contributes to the cytoprotective properties of monomethyl fumarate. (p1.150). Neurology, April 2015. URL: http://dx.doi.org/10.1212/wnl.84.14_supplement.p1.150, doi:10.1212/wnl.84.14_supplement.p1.150. This article has 1 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1212/wnl.84.14_supplement.p1.150)

[2. (Brennan2017The) Melanie S. Brennan, Maria F. Matos, Karl E. Richter, Bing Li, and Robert H. Scannevin. The nrf2 transcriptional target, osgin1, contributes to monomethyl fumarate-mediated cytoprotection in human astrocytes. Scientific Reports, February 2017. URL: http://dx.doi.org/10.1038/srep42054, doi:10.1038/srep42054. This article has 52 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/srep42054)

[3. (Tsai2017Docosahexaenoic) Chia-Han Tsai, You-Cheng Shen, Haw-Wen Chen, Kai-Li Liu, Jer-Wei Chang, Pei-Yin Chen, Chen-Yu Lin, Hsien-Tsung Yao, and Chien-Chun Li. Docosahexaenoic acid increases the expression of oxidative stress-induced growth inhibitor 1 through the pi3k/akt/nrf2 signaling pathway in breast cancer cells. Food and Chemical Toxicology, 108:276–288, October 2017. URL: http://dx.doi.org/10.1016/j.fct.2017.08.010, doi:10.1016/j.fct.2017.08.010. This article has 52 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.fct.2017.08.010)

[4. (Liu2014AlleleSpecific) Ming Liu, Yan Li, Leilei Chen, Tim Hon Man Chan, Yangyang Song, Li Fu, Ting–Ting Zeng, Yong–Dong Dai, Ying–Hui Zhu, Yan Li, Juan Chen, Yun–Fei Yuan, and Xin–Yuan Guan. Allele-specific imbalance of oxidative stress-induced growth inhibitor 1 associates with progression of hepatocellular carcinoma. Gastroenterology, 146(4):1084-1096.e5, April 2014. URL: http://dx.doi.org/10.1053/j.gastro.2013.12.041, doi:10.1053/j.gastro.2013.12.041. This article has 31 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1053/j.gastro.2013.12.041)